Suppr超能文献

采用多学科方法进行希佩尔-林道病的遗传咨询和长期监测。

Genetic Counseling and Long-Term Surveillance Using a Multidisciplinary Approach in von Hippel-Lindau Disease.

机构信息

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

bioMérieux Korea, Seoul, Korea.

出版信息

Ann Lab Med. 2022 May 1;42(3):352-357. doi: 10.3343/alm.2022.42.3.352.

Abstract

BACKGROUND

von Hippel-Lindau (VHL) disease is an autosomal dominant disorder caused by variants of the VHL tumor suppressor gene (). Early detection and treatment are essential to prevent morbidity and mortality. We evaluated the effectiveness of surveillance strategies and the utility of a VHL clinic with a multidisciplinary team for the first time in Korea.

METHODS

The VHL clinic was organized at the Samsung Medical Center in 2011 and consisted of a multidisciplinary team, including an endocrinologist, urologist, general surgeon, neurosurgeon, ophthalmologist, otolaryngologist, and radiologist. Biochemical and imaging surveillance and personalized genetic counseling were conducted at the VHL clinic and patients were referred to the necessary departments upon detection of disease manifestation. We divided the patients in three groups (I-III) based on their compliance to VHL clinic attendance.

RESULTS

Between 2011 and 2018, 50 VHL patients were identified by molecular analysis and referred to the VHL clinic. Most patients regularly participated in imaging of the central nervous system (43/50, 86.0%) and of the abdomen (46/50, 92.0%). However, there were differences in compliance to determination of the catecholamine level, audiometry, and ophthalmic examination among the three groups.

CONCLUSIONS

We present the results of using a multidisciplinary team approach and showed that the VHL clinic strategy is useful for the comprehensive surveillance and management of VHL disease. We hope that VHL clinics will be widely set up in hospitals to improve prognosis in patients with VHL.

摘要

背景

von Hippel-Lindau(VHL)病是一种常染色体显性遗传疾病,由 VHL 肿瘤抑制基因()的变异引起。早期发现和治疗对于预防发病率和死亡率至关重要。我们首次在韩国评估了监测策略的有效性和多学科团队 VHL 诊所的实用性。

方法

VHL 诊所于 2011 年在三星医疗中心成立,由内分泌学家、泌尿科医生、普通外科医生、神经外科医生、眼科医生、耳鼻喉科医生和放射科医生组成的多学科团队组成。在 VHL 诊所进行生化和影像学监测以及个性化基因咨询,并在发现疾病表现时将患者转介到必要的科室。我们根据患者对 VHL 诊所就诊的依从性将患者分为三组(I-III 组)。

结果

2011 年至 2018 年间,通过分子分析鉴定了 50 名 VHL 患者,并将其转介至 VHL 诊所。大多数患者定期接受中枢神经系统(43/50,86.0%)和腹部(46/50,92.0%)的影像学检查。然而,三组患者在测定儿茶酚胺水平、听力测试和眼科检查的依从性方面存在差异。

结论

我们介绍了使用多学科团队方法的结果,并表明 VHL 诊所策略对于 VHL 疾病的全面监测和管理是有用的。我们希望在医院广泛设立 VHL 诊所,以改善 VHL 患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02d6/8677470/10c986e2e02f/alm-42-3-352-f1.jpg

相似文献

2
Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
Int J Neurosci. 2018 Feb;128(2):117-124. doi: 10.1080/00207454.2017.1372436. Epub 2017 Sep 13.
3
Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease.
BMC Med Genet. 2010 Jan 12;11:4. doi: 10.1186/1471-2350-11-4.
4
Von Hippel-Lindau syndrome. A pleomorphic condition.
Cancer. 1999 Dec 1;86(11 Suppl):2478-82.
6
Von Hippel-Lindau disease: a single gene, several hereditary tumors.
J Endocrinol Invest. 2018 Jan;41(1):21-31. doi: 10.1007/s40618-017-0683-1. Epub 2017 Jun 6.
7
9
Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
Scand J Gastroenterol. 2015 Mar;50(3):360-7. doi: 10.3109/00365521.2014.992364. Epub 2015 Jan 6.
10
von Hippel-Lindau disease: surveillance strategy for endolymphatic sac tumors.
Genet Med. 2011 Dec;13(12):1032-41. doi: 10.1097/GIM.0b013e31822beab1.

引用本文的文献

2
Genotype-phenotype correlation of ocular von Hippel-Lindau disease in Koreans.
PLoS One. 2024 Oct 7;19(10):e0311665. doi: 10.1371/journal.pone.0311665. eCollection 2024.

本文引用的文献

2
Review of the Neurological Implications of von Hippel-Lindau Disease.
JAMA Neurol. 2018 May 1;75(5):620-627. doi: 10.1001/jamaneurol.2017.4469.
3
A Review of Von Hippel-Lindau Syndrome.
J Kidney Cancer VHL. 2017 Aug 2;4(3):20-29. doi: 10.15586/jkcvhl.2017.88. eCollection 2017.
4
von Hippel-Lindau development in children and adolescents.
Am J Med Genet A. 2017 Sep;173(9):2381-2394. doi: 10.1002/ajmg.a.38324. Epub 2017 Jun 26.
5
Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark.
Eur J Hum Genet. 2017 Feb;25(3):301-307. doi: 10.1038/ejhg.2016.173. Epub 2016 Dec 14.
7
Personalized Medicine for Nervous System Manifestations of von Hippel-Lindau Disease.
Front Surg. 2016 Jun 30;3:39. doi: 10.3389/fsurg.2016.00039. eCollection 2016.
8
Von Hippel-Lindau Disease: Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome.
J Clin Oncol. 2016 Jun 20;34(18):2172-81. doi: 10.1200/JCO.2015.65.6140. Epub 2016 Apr 25.
9
HIF2a inhibitors for the treatment of VHL disease.
Oncotarget. 2015 Sep 15;6(27):23036-7. doi: 10.18632/oncotarget.4564.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验